Valuation: Biogen Inc.

Market Cap 30.36B 26.64B 24.81B 22.82B 42.77B 2,900B 43.51B 294B 115B 1,438B 114B 111B 4,969B P/E 2026 *
37.7x
P/E 2027 * 16.3x
Enterprise Value 34.98B 30.7B 28.59B 26.3B 49.29B 3,342B 50.14B 339B 133B 1,657B 131B 128B 5,727B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.18x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+4.52%
1 week+9.21%
Current month-0.05%
1 month-0.32%
3 months+11.09%
6 months+22.57%
Current year+22.70%
1 week 196.92
Extreme 196.915
218.59
1 month 186.02
Extreme 186.025
219.02
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

1,505 0.0010%
9/6/26 Free

Director

1,505 0.0010%
9/6/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+4.52%+9.21%+68.84%-20.08% 30.36B
+0.42%+7.76%+25.72%-5.42% 70.73B
-0.20%+2.59%+34.88%+209.99% 54.27B
+0.26%+54.90%+54.90%+54.90% 49.28B
+7.15%+8.59%-52.92%-52.31% 39.94B
-2.17%+10.30%+65.07%+100.44% 25.96B
-0.82%-5.57%+67.90%-53.40% 22.14B
-0.22%-2.66%-4.47%+145.08% 19.96B
-1.41%+1.88%+81.80%+140.53% 16.77B
+1.33%+2.25%+67.59%+129.90% 16.72B
Average +0.89%+2.40%+40.93%+64.96% 34.61B
Weighted average by Cap. +1.08%+3.22%+34.67%+57.41%

Financials

2026 *2027 *
Net sales 10.06B 8.83B 8.22B 7.56B 14.18B 961B 14.42B 97.57B 38.19B 477B 37.78B 36.96B 1,647B 10.32B 9.06B 8.44B 7.76B 14.54B 986B 14.79B 100B 39.17B 489B 38.75B 37.91B 1,690B
Net income 965M 847M 789M 726M 1.36B 92.22B 1.38B 9.36B 3.66B 45.73B 3.62B 3.55B 158B 1.99B 1.74B 1.62B 1.49B 2.8B 190B 2.85B 19.26B 7.54B 94.12B 7.46B 7.3B 325B
Net Debt 4.63B 4.06B 3.78B 3.48B 6.52B 442B 6.63B 44.86B 17.56B 219B 17.37B 17B 757B 2.46B 2.16B 2.01B 1.85B 3.46B 235B 3.52B 23.84B 9.33B 116B 9.23B 9.03B 402B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
29/07/26 US$215.99 +5.05% 650,330
28/07/26 US$205.61 +2.73% 1,832,179
27/07/26 US$200.14 -1.01% 762,581
24/07/26 US$202.19 +0.78% 596,372
23/07/26 US$200.62 +1.46% 1,032,070
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
205.61USD
Average target price
228.76USD
Spread / Average Target
+11.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock